FDA action counts
| Total FDA actions | 6 |
|---|---|
| Warning letters | 0 |
| Recalls | 6 |
| Approval records | 0 |
| Form 483 inspection citations | 0 |
| Most recent action | August 19, 2026 |
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. Covidien, LP has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Enforcement history
On 2026-06-10, Argus HQ recorded an FDA recall for Covidien, LP, rated "high" severity in Argus HQ's classification: Covidien, LP — Class II recall: Covidien EndoStitch" Polysorb Single Use Loading Unit; Product numbers: 170053…. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Frequently asked questions
- Does Argus HQ track new FDA actions for Covidien, LP automatically?
- Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Covidien, LP is observed, this page's event count and history update automatically.
- How many FDA actions does Argus HQ track for Covidien, LP?
- 6 total: 0 warning letters, 6 recalls, 0 approval records, and 0 Form 483 inspection citations.
- What is the most recent FDA action on file for Covidien, LP?
- August 19, 2026. Argus HQ ingests new FDA enforcement records daily.
- Has Covidien, LP had product recalls?
- Yes, 6 recalls on file. See the full history below for each one.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
- Covidien, LP — Class II recall: Dermalon 88861757-31 DERMALON* 4-0 BLU 75CM C13 88861757-31 88861799-31… →
- Covidien, LP — Class II recall: V-Loc 90 Absorbable Wound Closure Device VLOC 90 0 VL 22 GS-21 VLOCM0336… →
- Covidien, LP — Class II recall: Surgipro SP-623 SURGIPRO* 2-0 BLU 75CM SC2 X36 SP-623 →
- Covidien, LP — Class II recall: V-Loc 180 Absorbable Wound Closure Device BOX BEDSIDE STAPLING IS KING BOX… →
- Covidien, LP — Class II recall: Surgipro II S8698GX SURGIPRO II BL 5/0 18 P-13 S8698GX →
- Covidien, LP — Class II recall: Covidien EndoStitch" Polysorb Single Use Loading Unit; Product numbers: 170053… →
Compare with
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Verified from FDA.gov · Last updated: Aug 19, 2026Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Covidien, LP's Complete FDA Record. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/covidien-lp
"Covidien, LP's Complete FDA Record." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/covidien-lp.
Argus HQ Research. "Covidien, LP's Complete FDA Record." Digital Empire Holdings LLC. Accessed August 27, 2026. https://argushq.ai/company/covidien-lp.
@misc{argushq_argushq_ai_company_covidien_lp_2026,
title = {Covidien, LP's Complete FDA Record},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/company/covidien-lp},
note = {Accessed: August 27, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗

